A developmental perspective on the controversy surrounding the use of SSRIs to treat pediatric depression

Am J Psychiatry. 2007 Sep;164(9):1304-6. doi: 10.1176/appi.ajp.2007.07050880.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Editorial

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Age Factors
  • Bipolar Disorder / chemically induced
  • Central Nervous System / drug effects
  • Central Nervous System / growth & development
  • Child
  • Child Development / drug effects
  • Child, Preschool
  • Depressive Disorder / drug therapy*
  • Drug Labeling
  • Humans
  • Risk Factors
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • United States
  • United States Food and Drug Administration / statistics & numerical data

Substances

  • Serotonin Uptake Inhibitors